Cerity Partners LLC Kaleido Biosciences, Inc. Transaction History

Cerity Partners LLC

  • $44.7 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$0.05 - $1.7 $797 - $27,115
-15,950 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$2.39 - $6.02 $119 - $301
-50 Reduced 0.31%
15,950 $38,000
Q3 2021

Oct 25, 2021
SELL
$5.36 - $7.99 $15,008 - $22,372
-2,800 Reduced 14.89%
16,000 $87,000
Q2 2021

Aug 11, 2021
BUY
$5.82 - $8.72 $1,746 - $2,616
300 Added 1.62%
18,800 $140,000
Q1 2021

Aug 11, 2021
BUY
$7.2 - $16.82 $133,200 - $311,170
18,500 New
18,500 $150,000

Others Institutions Holding KLDO

# of Institutions
2
Shares Held
2.65K
Call Options Held
0
Put Options Held
0
View Full List

About Kaleido Biosciences, Inc.

KLDO Quotes by TradingView
  • Ticker KLDO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,622,600
  • Description
  • Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...
More about KLDO
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email